https://shikonininhibitor.com/....lcd-supply-in-the-us
Model-adjusted mean E. coli O157H7 fecal prevalence estimates (standard mistake regarding the mean [SEM]) for DFM and control teams had been 8.2% (SEM = 2.2%) and 9.9per cent (SEM = 2.5%) in KS and 14.6% (SEM = 2.8%) versus 14.3per cent (SEM = 2.6%) in NE; prevalence did not vary dramatically between therapy teams at either site (KS, p = 0.51; NE, p = 0.92). Mean E. coli O157 supershedding prevalence estimates for DFM and control groups had been 2.2% (SEM = 0.7%) versus 1.8per cent (SEM = 0.7%) in KS (p = 0.66) and 6.7% (SEM = 1.5perc
Like
Comment
Share
